Search Results - "Shomron Ben-Horin"
-
1
Editorial: Finger in the dam—A clinical trial of long‐acting somatostatin for high‐output ostomies and fistulas
Published in Alimentary pharmacology & therapeutics (01-10-2024)“…LINKED CONTENT This article is linked to Timmer et al paper. To view this article, visit https://doi.org/10.1111/apt.18166…”
Get full text
Journal Article -
2
Systematic review with meta‐analysis: environmental and dietary differences of inflammatory bowel disease in Eastern and Western populations
Published in Alimentary pharmacology & therapeutics (01-02-2022)“…Summary Background While the incidence of inflammatory bowel disease (IBD) has stabilised in the West, it is still increasing in several newly industrialised…”
Get full text
Journal Article -
3
Letter: Chinese herbal medicine Curcumin–QingDai (CurQD)—A good treatment option for active ulcerative colitis? Authors' reply
Published in Alimentary pharmacology & therapeutics (01-09-2023)“…LINKED CONTENT This article is linked to Yanai et al papers. To view these articles, visit https://doi.org/10.1111/apt.17538 and…”
Get full text
Journal Article -
4
Letter: loss of response to anti‐TNFα agents in patients with inflammatory bowel disease depends on treatment duration
Published in Alimentary pharmacology & therapeutics (01-02-2022)“…LINKED CONTENT This article is linked to Schultheiss et al papers. To view these articles, visit https://doi.org/10.1111/apt.16605 and…”
Get full text
Journal Article -
5
Editorial: tofacitinib post‐marketing safety reports among ulcerative colitis patients
Published in Alimentary pharmacology & therapeutics (01-01-2022)“…LINKED CONTENT This article is linked to Rubin et al papers. To view these articles, visit https://doi.org/10.1111/apt.16619…”
Get full text
Journal Article -
6
Differences in disease characteristics and treatment exposures between paediatric and adult‐onset inflammatory bowel disease using a registry‐based cohort
Published in Alimentary pharmacology & therapeutics (01-11-2024)“…Summary Background Previous studies highlighted a more extensive phenotype for paediatric‐onset than adult‐onset inflammatory bowel disease (IBD). However,…”
Get full text
Journal Article -
7
Editorial: which biologic is next for ulcerative colitis patients who fail a subcutaneous anti‐TNF?
Published in Alimentary pharmacology & therapeutics (01-06-2020)“…LINKED CONTENT This article is linked to Hupé et al paper. To view this article, visit https://doi.org/10.1111/apt.15680…”
Get full text
Journal Article -
8
Editorial: biomarker predictors of non‐response to TNFα antagonists—the quest continues
Published in Alimentary pharmacology & therapeutics (01-04-2019)“…Linked ContentThis article is linked to Verstockt et al papers. To view these articles, visit https://doi.org/10.1111/apt.15126, and…”
Get full text
Journal Article -
9
Real‐world multicentre observational study including population pharmacokinetic modelling to evaluate the exposure–response relationship of vedolizumab in inflammatory bowel disease: ERELATE Study
Published in Alimentary pharmacology & therapeutics (01-08-2022)“…Summary Background ERELATE was a phase 4, multinational, retrospective, observational study. Aim To evaluate the relationship between intravenous vedolizumab…”
Get full text
Journal Article -
10
Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy
Published in Alimentary pharmacology & therapeutics (01-07-2020)“…Summary Background Ustekinumab is effective in Crohn's disease. However, a substantial proportion of patients will not respond or lose response to ustekinumab…”
Get full text
Journal Article -
11
Real‐world experience with Curcumin–QingDai combination for patients with active ulcerative colitis: A retrospective multicentre cohort study
Published in Alimentary pharmacology & therapeutics (01-07-2023)“…Summary Background Curcumin and QingDai (QD, Indigo) have been shown to be effective for treating active ulcerative colitis (UC). Aim To evaluate the…”
Get full text
Journal Article -
12
Terminal Ileum Thickness During Maintenance Therapy Is a Predictive Marker of the Outcome of Infliximab Therapy in Crohn Disease
Published in Inflammatory bowel diseases (01-10-2020)“…Abstract Background Mucosal healing has been associated with long-term response to therapy for Crohn disease (CD). However, little is known about the…”
Get full text
Journal Article -
13
The role of multimodal treatment in Crohn′s disease patients with perianal fistula: a multicentre retrospective cohort study
Published in Alimentary pharmacology & therapeutics (01-11-2018)“…Summary Background Treatment paradigms for Crohn′s disease with perianal fistulae (CD‐pAF) are evolving. Aims To study the impact of multimodality treatment in…”
Get full text
Journal Article -
14
Prediction of patency capsule retention in known Crohn's disease patients by using magnetic resonance imaging
Published in Gastrointestinal endoscopy (01-01-2016)“…Background and Aims Evaluation of small-bowel patency is recommended before swallowing video capsule endoscopy to prevent capsule retention. This study aimed…”
Get full text
Journal Article -
15
Capsule Endoscopy in Inflammatory Bowel Disease: Panenteric Capsule Endoscopy and Application of Artificial Intelligence
Published in Gut and liver (01-07-2023)“…Video capsule endoscopy (VCE) of the small-bowel has been proven to accurately diagnose small-bowel inflammation and to predict future clinical flares among…”
Get full text
Journal Article -
16
Reprogrammed and transmissible intestinal microbiota confer diminished susceptibility to induced colitis in TMF⁻/⁻ mice
Published in Proceedings of the National Academy of Sciences - PNAS (01-04-2014)“…Tata Element Modulatory Factor (TMF/ARA160) is a multifunctional Golgi-associated protein, which accumulates in colonic enterocytes and goblet cells. Mice…”
Get full text
Journal Article -
17
Impact of COVID‐19 outbreak on the care of patients with inflammatory bowel disease: A comparison before and after the outbreak in South China
Published in Journal of gastroenterology and hepatology (01-03-2021)“…Background and Aims Epidemics pose a great challenge to health care of patients. However, the impact of unprecedented situation of COVID‐19 outbreak on health…”
Get full text
Journal Article -
18
A novel PillCam Crohn’s capsule score (Eliakim score) for quantification of mucosal inflammation in Crohn’s disease
Published in United European gastroenterology journal (01-06-2020)“…Introduction Capsule endoscopy is an important modality for monitoring of Crohn’s disease. Recently, a novel panenteric capsule, PillCam Crohn’s (Medtronic,…”
Get full text
Journal Article -
19
Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn’s disease: systematic review and meta-analysis
Published in Therapeutic advances in gastroenterology (01-01-2018)“…Background: Anastomotic recurrence is frequent in patients with Crohn’s disease (CD) following ileocecal resection. The degree of endoscopic recurrence,…”
Get full text
Journal Article -
20
Change in bowel habits during menstruation: are IBD patients different?
Published in Therapeutic advances in gastroenterology (2020)“…Background and aim: Many female inflammatory bowel disease (IBD) patients report symptoms exacerbation before and during menses. Our aim was to characterize…”
Get full text
Journal Article